You just read:

Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed

News provided by

Analysts' Corner

Dec 04, 2013, 08:00 ET